Table 2.
p-mTOR + (n = 57) |
p-mTOR- (n = 14) |
p-value | |||
---|---|---|---|---|---|
No. of patients | % | No. of patients | % | ||
ALK (n = 71) |
|
|
|
|
|
ALK+ |
39 of 57 |
68 |
5 of 14 |
36 |
0.024* |
ALK- |
18 of 57 |
32 |
9 of 14 |
64 |
|
p-AKT (n = 71) |
|
|
|
|
|
p-AKT+ |
47 of 57 |
83 |
7 of 14 |
50 |
0.011* |
p-AKT- |
10 of 57 |
17 |
7 of 14 |
50 |
|
ALK + (n = 44) |
|
|
|
|
|
ALK(n + c) |
30 of 39 |
77 |
3 of 5 |
60 |
0.431 |
ALK(c) | 9 of 39 | 23 | 2 of 5 | 40 |
*Statistically significant value.